Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intrauterine vertical SARS-CoV-2 infection: a case confirming transplacental transmission followed by divergence of the viral genome.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Achieving orphan designation for placental insufficiency: annual incidence estimations in Europe.

BJOG : an international journal of obstetrics and gynaecology·2018
Same author

OS089. Elevated levels of the heme scavenger alpha-1-microglobulin in maternal plasma at the end of first trimester in patients who subsequently develop preeclampsia.

Pregnancy hypertension·2015
Same author

P11. Differentially expressed micro-RNAs in microparticles from haemoglobin perfused placentas.

Pregnancy hypertension·2015
Same author

The cysteine 34 residue of A1M/α1-microglobulin is essential for protection of irradiated cell cultures and reduction of carbonyl groups.

Free radical research·2013
Same author

Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease.

Molecular human reproduction·2011

Related Experiment Video

Updated: May 26, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Review: Biochemical markers to predict preeclampsia.

U D Anderson1, M G Olsson, K H Kristensen

  • 1Department of Obstetrics and Gynecology, Department of Clinical Sciences, Lund University Hospital, Lund University, Tornavägen 10, Lund, Sweden.

Placenta
|December 27, 2011
PubMed
Summary

Early detection of preeclampsia (PE) using biochemical markers like PAPP-A and HbF in the first trimester can improve maternal health. These markers aid in identifying high-risk pregnancies, optimizing delivery, and reducing premature births.

More Related Videos

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

Related Experiment Videos

Last Updated: May 26, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

Area of Science:

  • Obstetrics and Gynecology
  • Biochemistry
  • Maternal-Fetal Medicine

Background:

  • Preeclampsia (PE) affects 3-8% of pregnancies globally, causing significant maternal and fetal mortality.
  • No specific treatment exists for PE, highlighting the need for early detection and prediction.
  • Reliable biochemical markers are crucial for improving maternal health outcomes and managing PE.

Purpose of the Study:

  • To review general and first-trimester biochemical markers for preeclampsia prediction and diagnosis.
  • To discuss the potential of specific markers including angiogenic factors, placental proteins, and kidney markers.
  • To evaluate the efficacy of markers like PAPP-A, HbF, s-Flt-1/PlGF, and A1M.

Main Methods:

  • Review of existing literature on preeclampsia biochemical markers.
  • Analysis of specific markers such as PAPP-A, HbF, s-Flt-1/PlGF, s-Endoglin, PP13, cystatin-C, and α₁-microglobulin (A1M).
  • Assessment of marker sensitivity, specificity, and optimal timing for detection (e.g., first trimester, mid-second trimester).

Main Results:

  • PAPP-A and HbF show potential for first-trimester PE prediction (70% sensitivity, 95% specificity).
  • PAPP-A requires combination with Doppler ultrasound for sensitivity comparable to HbF/A1M.
  • Soluble Flt-1/PlGF demonstrate high sensitivity from the mid-second trimester; PlGF is useful from late first trimester.

Conclusions:

  • Biochemical marker screening can reduce healthcare costs and improve maternal outcomes through early PE detection.
  • Early identification of high-risk pregnancies allows for optimized monitoring and timely delivery, potentially reducing premature births.
  • Combining markers and ultrasound may enhance diagnostic accuracy for preeclampsia.